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a b s t r a c t
Evidence suggests substantial declines in HIV prevalence in parts of sub-Saharan Africa. However, the
observed aggregate declines at the national level may obscure local variations in the temporal dynamics
of the infection. Using spatial scan statistics, we identiﬁed marked spatial variability in the within-
country declines in HIV prevalence in Tanzania, Malawi, Kenya, and Zimbabwe. Our study suggests that
the declines in the national HIV prevalence in some of the SSA countries may not be representative of
downward trends in prevalence in areas of high HIV prevalence, as much as the result of sharp declines
in prevalence in areas of already low HIV prevalence. Our ﬁndings provide insights for resource
allocation and HIV prevention interventions in these countries.
& 2014 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
1. Introduction
Recent evidence suggests substantial declines in HIV preva-
lence in parts of West, Southern and East Africa (UNAIDS, 2010;
UNAIDS WHO, 2011). HIV incidence appears to have declined by
more than 50% between 2001 and 2011 in 25 low-and middle-
income countries, mostly from sub-Saharan Africa (SSA) (UNAIDS,
2012). HIV prevalence has declined by about 10% from 2000 to
2012 in Cameroon and Zambia, and by about 30% in Kenya and
Malawi (UNAIDS WHO, 2013). The drivers of such HIV prevalence
declines are not well understood (Awad and Abu-Raddad, 2014).
Several mechanisms have been proposed to explain these declines
including reduction in sexual risk behavior (Awad and Abu-
Raddad, 2014; Hallett et al., 2006; 2009; Kilian et al., 1999;
UNAIDS, 1999), natural epidemic dynamics (Garnett et al., 2006),
increased HIV-associated mortality (UNAIDS, 1999; Walker et al.,
2008a), impact of interventions (Stoneburner and Low-Beer,
2004), and heterogeneity in host susceptibility to HIV infection
(Nagelkerke et al., 2009).
Despite reported HIV prevalence declines at the national level,
a number of studies have suggested striking geographical
differences in HIV prevalence trends. For instance, two studies
using antenatal-clinic data among young women in Zambia
reported diverse declines during the period 1994–2008 in urban
settings ranging between 10% and 68%, and in rural settings
ranging between 0% and 86% (Kayeyi et al., 2012; Sandøy et al.,
2006).
These studies highlighted the possibility that the observed
declines in HIV prevalence could reﬂect aggregate measures at
the national level, obscuring local variations in the temporal
dynamics of the infection. Motivated by theoretical grounds
(Abu-Raddad et al., 2008; Alsallaq et al., 2009; Anderson and
May, 1991; Awad et al., 2012; Cuadros et al., 2013), and based on a
recent characterization of HIV infection clustering in SSA (Cuadros
et al., 2013), we hypothesized that HIV prevalence declines would
be higher in areas with low HIV prevalence (closer to the epidemic
threshold for HIV in the general population) compared to areas
with high HIV prevalence (well above the epidemic threshold).
In this article, we examined the plausibility of such hypothesis by
characterizing the spatial variability in HIV prevalence declines in
different countries in SSA.
2. Methods
The main source of data in our study was the Demographic and
Health Surveys (DHS) for countries in SSA with at least two rounds
including HIV serological biomarker survey and the geographical
coordinates of each survey data point; that is all countries where
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we could conduct this analysis. As a result, a total of 10 countries
from SSA were analyzed: Cameroon (2004, 2011), Ethiopia (2005,
2011), Kenya (2003, 2008–2009), Lesotho (2004, 2009), Malawi
(2004, 2010), Mali (2001, 2006), Rwanda (2005, 2010), Senegal
(2005, 2010–2011), Tanzania (2003–2004, 2007–2008, 2011–
2012), and Zimbabwe (2005–2006, 2010–2011).
We used spatial scan statistics analyses (Kulldorff, 1997) to
identify the geographical clusters with high numbers of HIV
Fig. 1. Geographical clustering of HIV infection in Tanzania, Malawi, Kenya, and Zimbabwe. Spatial locations of the high HIV prevalence clusters in Tanzania ((a) and (b)),
Malawi ((c) and (d)), Kenya ((e) and (f)), and Zimbabwe ((g) and (h)). Continuous surfaces of HIV prevalence within a country were generated using the inverse distance
weighted mapping algorithm (ESRI, 2004).
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infections in the most recent round of the DHS conducted in each
country. This methodology identiﬁes clusters with higher numbers
of cases (here HIV infections) than expected under spatial ran-
domness, and then evaluates their statistical signiﬁcance by
gradually scanning a circular window that spans the region of
study. The area in the circular window varied in size from zero to a
maximum radius. We used the default scanning setting of a
maximum spatial cluster size of 50% of the study population.
For each potential cluster detected, a likelihood ratio test was
computed assuming that the number of HIV infections in each circle
is an independent Binomial random variable. Afterwards, an asso-
ciated P-value was computed through Monte Carlo simulations and
used to evaluate the statistical signiﬁcance of each cluster. Clusters
with a Po0.05 were identiﬁed as statistically signiﬁcant, and
included for further epidemiological description. The scan statistics
were adjusted for the spatially heterogeneous population densities,
and the analysis was conditioned on the total number of cases
observed. HIV prevalence in these clusters was then estimated for
the available previous DHS rounds. The trend in HIV prevalence was
assessed at the national level and for the clusters with high HIV
prevalence and outside these clusters, using the chi-square test for
trend for Tanzania (as three rounds are available), and the chi-
square test for the other countries (only two rounds are available for
each country).
We also described several variables in the identiﬁed clusters of
high HIV prevalence using the last DHS round conducted in each
country. These variables included type of place of residence (urban
or rural), age, highest educational level, wealth index, marital
status, number of sexual partners during the last year, and being
ever tested for HIV.
3. Results
Our analyses identiﬁed discernible patterns in the spatio-temporal
dynamics of HIV prevalence in four of the countries included in our
study: Tanzania, Malawi, Kenya, and Zimbabwe (Table S1 in Supple-
mentary material). No statistically signiﬁcant patterns were discerned
in Cameroon, Ethiopia, Lesotho, Mali, Rwanda, and Senegal.
We identiﬁed three clusters of high HIV prevalence in Tanzania,
and one cluster in each of the remaining countries; Malawi, Kenya,
and Zimbabwe (Fig. 1). Table 1 includes a general description of
the clusters identiﬁed in each country. Cluster sizes ranged from
6 km radius in size for a cluster located in Tanzania, to 307 km
radius in size for a cluster located also in Tanzania. Most of the
population within the identiﬁed clusters lived in rural areas, with
the exception of Cluster 2 in Tanzania, located in the urban area of
Dar es Salaam. The bar charts in Fig. 2 illustrate the national HIV
prevalence in each DHS round, and HIV prevalence within and
outside of the identiﬁed high HIV prevalence clusters.
The national HIV prevalence in Tanzania declined by 27% from
2003 to 2011 (Po0.001), however no decline was observed within
the clusters of high HIV prevalence collectively (P¼0.14). Indivi-
dually (Fig. 1a and b), HIV prevalence remained stable in the
southern cluster (P¼0.5), declined but not signiﬁcantly in the
eastern cluster (P¼0.3), and increased signiﬁcantly in the northern
cluster (P¼0.01). Meanwhile, HIV prevalence outside the high HIV
prevalence clusters declined by 30% (Po0.001).
The national HIV prevalence in Malawi declined with border-
line signiﬁcance by 12% (P¼0.09), but no decline was observed
within the cluster of high HIV prevalence (P¼0.76; Fig. 1c and d).
Meanwhile, HIV prevalence outside the high HIV prevalence
cluster declined by 32% (Po0.001).
The national HIV prevalence in Kenya declined but not sig-
niﬁcantly by 6% (P¼0.62). A signiﬁcant increase of 20.1% in HIV
prevalence was observed within the high HIV prevalence cluster
(P¼0.01; Fig. 1e and f). HIV prevalence outside the high HIV
prevalence cluster declined but not signiﬁcantly by 11.3% (P¼0.11).
The national HIV prevalence in Zimbabwe declined by 16.7%
(Po0.001). A signiﬁcant increase of 18.5% in HIV prevalence was
observed within the high HIV prevalence cluster (Po0.001; Fig. 1g
and h). Meanwhile, HIV prevalence outside the high HIV preva-
lence cluster declined by 15.4% (Po0.001).
There were generally minor differences in the characteristics of
the population living within versus outside the clusters, with
apparently no discernable associations of epidemiological signiﬁ-
cance (Tables S2–S5 in Supplementary materials). The percentage
of the population who has ever tested for HIV was higher within
the clusters versus outside the clusters, but only by a small margin.
The percentage of the population that lived in urban areas within
the clusters was generally higher than that outside the clusters;
16.2% versus 11.7% in Malawi, 39.3% versus 18.9% in Tanzania, and
52.0% versus 31.1% in Zimbabwe. However, the opposite pattern
Table 1
Description of the identiﬁed HIV clusters in the most recent Demographic and



















Cluster 1 307 91 14.3 (13.8–14.8) 13.6 (12.7–14.6)
Cluster 2 6 29 6.0 (5.7–6.4) 85.3 (83.1–87.3)
Cluster 3 70 15 3.0 (2.8–3.3) 13.6 (10.9–16.7)
Total within clusters – 135 23.3 (22.7–23.9) 39.4 (37.9–40.8)
Malawi
Cluster1 162 301 34.9 (34.1–35.) 16.9 (15.9–18.0)
Kenya
Cluster 1 68 69 19.4 (18.4–20.3) 18.5 (16.4–20.7)
Zimbabwe
Cluster 1 168 99 21.8 (21.1–22.5) 40.3 (38.8–42.1)
Fig. 2. Temporal trends in the clustering of HIV infection in Tanzania, Malawi, Kenya, and Zimbabwe. Bar charts illustrating the temporal trend in national HIV prevalence (a),
in HIV prevalence outside the high HIV prevalence clusters (b), and in HIV prevalence within the high HIV prevalence clusters (c).
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was observed in Kenya; 22.3% of the population were urban within
the cluster versus 32.8% of the population were urban outside the
cluster.
4. Discussion
Our results suggest striking spatial variability in the declines in HIV
prevalence in Tanzania, Malawi, Kenya, and Zimbabwe. Even in the
presence of declining national HIV prevalence, HIV prevalence within
clusters of high prevalence either did not decline or increased (Fig. 2).
HIV national prevalence declines in Malawi, Tanzania, and Zimbabwe
were driven by rapid changes in prevalence outside of the core areas
of intense HIV transmission, while HIV prevalence within the high HIV
prevalence clusters in Kenya and Zimbabwe has increased.
The drivers of such spatial variability in HIV prevalence
declines are not clear. We could not identify epidemiologic
associations of signiﬁcance to explain the variability in HIV
prevalence trends. Though HIV testing appeared higher within
the high HIV prevalence clusters, the differences were small, and
may be explained by a higher coverage of recent interventions in
areas of higher HIV prevalence. Further research work is needed to
examine the differences between areas of rapid declines and those
of limited or no declines using studies speciﬁcally designed to
examine these effects.
Several mechanisms may contribute to explaining these ﬁnd-
ings. The spatial differences in HIV prevalence declines may reﬂect
dynamical effects related to how far is HIV transmission in the
general population from the epidemic threshold of sustainability
(Abu-Raddad et al., 2008; Alsallaq et al., 2009; Anderson and May,
1991; Awad et al., 2012; Cuadros et al., 2013). They may also reﬂect
heterogeneity in epidemic phases or changes in sexual risk
behavior, or uptake of prevention and treatment interventions.
Moreover, migration patterns of high-risk individuals could also
affect the spatio-temporal distribution of the infection (UNAIDS,
2005; Walker et al., 2008b).
We examined the spatio-temporal patterns of HIV prevalence
in all SSA countries where at least two rounds of DHS with
biomarker and geographic information were available. We could
not, however, identify variable statistically-signiﬁcant spatio-tem-
poral patterns in Cameroon, Ethiopia, Lesotho, Mali, Rwanda, and
Senegal. Therefore, our ﬁndings for Tanzania, Malawi, Kenya, and
Zimbabwe may not be generalizable to other countries in SSA. It is
not clear, however, whether the lack of geographical differences in
HIV prevalence declines in the other countries reﬂects lack of
effect, or that the changes in prevalence have not yet been
substantial enough to be identiﬁed, with statistical signiﬁcance.
Several limitations could have affected our results. The cross-
sectional nature of the data used in this study and the limited
availability of geographic and biomarker information have restricted
our ability to consider more countries in SSA, and to examine
temporal trends over longer periods of time. Given the multiple
logistical difﬁculties in conducting the DHS, some of our measures
could have been affected by inherent biases in the data such as the
variability in response rates to HIV testing and under-sampling of
mobile individuals and key subpopulations at risk (Marston et al.,
2008; Mishra et al., 2008). An additional potential bias is the global
positioning system displacement process of the DHS sampling data
points, used to preserve the conﬁdentiality of the data points (Burget
et al., 2013), This process may have impacted the precision of the
geographical location of the clusters by few kilometers.
5. Conclusion
Our ﬁndings suggest that the national HIV prevalence declines in
several countries in SSA may not be representative of general
declines in prevalence within these countries. The national declines
in prevalence appear to be driven by sharp declines in prevalence in
areas of already lower HIV prevalence. In some of the areas with
already high HIV prevalence within a country, the prevalence
appears to be sustained or even increasing. National estimations
of HIV prevalence may obscure local variations and areas with
stable or increasing intense HIV transmission. Further research
work to generate sub-national estimations of HIV prevalence and
to understand the drivers of the spatio-temporal variability, may
increasingly become relevant as HIV programs are planned and
implemented. Spatially-targeted prevention interventions could be
the legacy of the waning HIV prevalence in this part of the globe.
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